14-day Premium Trial Subscription Try For FreeTry Free
U.S. stock futures traded higher this morning. Here are some big stocks recording losses in today’s pre-market trading session. Cameco Corporation (NYSE: CCJ) shares dropped 11.7% to $22.75 in pre-
Inovio Pharmaceuticals, Inc. (NASDAQ:INO ) H.C. Wainwright 24th Annual Global Investment Conference September 12, 2022 7:00 AM ET Company Participants Jacqueline Shea - President and CEO Conference Ca

1 Green Flag and 1 Red Flag For Inovio Pharmaceuticals

02:53pm, Sunday, 11'th Sep 2022 The Motley Fool
Can the company still count on its coronavirus-related efforts?
Can the company still count on its coronavirus-related efforts?

Emergent (EBS) Initiates Study on Lassa Virus Vaccine Candidate

02:12pm, Wednesday, 07'th Sep 2022 Zacks Investment Research
Emergent BioSolutions (EBS) initiates an early-stage study evaluating its Lassa virus vaccine candidate, EBS-LASV, for the prevention of Lassa fever.
Gainers Invitae Corporation (NYSE: NVTA) surged 278.5% to close at $8.63 after the company reported better-than-expected Q2 EPS. BioAtla, Inc. (NASDAQ: BCAB) jumped 83.1% to close at $6.61 on Wednesd

Why Inovio Pharmaceuticals Is Gaining Today

07:32pm, Wednesday, 10'th Aug 2022 The Motley Fool
Its newly announced cost-saving measures are getting a warm reception.

Why Inovio Pharmaceuticals Is Gaining Today

03:32pm, Wednesday, 10'th Aug 2022
Its newly announced cost-saving measures are getting a warm reception.

Inovio Pharmaceuticals (INO) Q2 2022 Earnings Call Transcript

04:01am, Wednesday, 10'th Aug 2022 The Motley Fool
INO earnings call for the period ending June 30, 2022.

Inovio Pharmaceuticals (INO) Reports Q2 Loss, Tops Revenue Estimates

11:25pm, Tuesday, 09'th Aug 2022 Zacks Investment Research
Inovio (INO) delivered earnings and revenue surprises of -53.33% and 264.65%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
Inovio (INO) delivered earnings and revenue surprises of -53.33% and 264.65%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
Inovio Pharmaceuticals, Inc. (NASDAQ:INO ) Q2 2022 Earnings Conference Call August 9, 2022 4:30 PM ET Company Participants Thomas Hong - IR Jacqueline Shea - CEO, President & Director Michael Sumner -
Investing in biotech stocks carries both risk and reward. This article highlights two biotech companies that may appeal to specific investing styles
Inovio (INO) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
The World Health Organization (WHO) on Saturday declared the monkeypox outbreak a global emergency, its highest level of alert. WHO Director-General Tedros Adhanom Ghebreyesus said more than 16,0
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE